AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Cerus Corporation to Present at the Stephens Nashville Investment Conference

November 8, 2019

CONCORD, Calif.--(BUSINESS WIRE)--Nov 8, 2019--

Cerus Corporation (Nasdaq:CERS) announced today that Kevin D. Green, Cerus’ chief financial officer, will present at the Stephens Nashville Investment Conference on Wednesday, November 13, 2019 at 10:30 a.m. CT.

A live webcast of the presentation will be available on the Investor Relations page of the Cerus web site at http://www.cerus.com/ir. A replay of the webcast will be available for approximately two weeks following the completion of the event.

ABOUT CERUS

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Based in Concord, California, our employees are dedicated to deploying and supplying vital technologies and pathogen-protected blood components for blood centers, hospitals and ultimately patients who rely on safe blood. With the INTERCEPT Blood System, we are focused on protecting patients by delivering the full complement of reliable products and expertise for transfusion medicine. Cerus develops and markets the INTERCEPT Blood System, and remains the only company in the blood transfusion space to earn both CE Mark and FDA approval for pathogen reduction of both platelet and plasma components. Cerus currently markets and sells the INTERCEPT Blood System in the United States, Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The INTERCEPT Red Blood Cell system is in clinical development. For more information about Cerus, visit www.cerus.com.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191108005168/en/

CONTACT: Tim Lee – Investor Relations Director

Cerus Corporation

925-288-6137

KEYWORD: CALIFORNIA TENNESSEE UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH HOSPITALS CLINICAL TRIALS CARDIOLOGY BIOTECHNOLOGY

SOURCE: Cerus Corporation

Copyright Business Wire 2019.

PUB: 11/08/2019 08:30 AM/DISC: 11/08/2019 08:30 AM

http://www.businesswire.com/news/home/20191108005168/en